Applying the 80/20 rule of outcomes from causes to metabolic health.

How the ‘net carbs’ concept came to be, and was eventually bastardized by the food industry.

Five regions of the planet were claimed to hold the key to living past 100. Research by Dr. Saul Newman of the Oxford Institute of Population Ageing shows the truth isn’t that simple.

Why it matters that placebo-controlled trials can never be repeated.

Dr. Palmer discussed the rising prevalence of mental illness and the limited success of current treatments like medications and therapy, which often fail to address the underlying causes.

Professor Thomas Seyfried presents at a BSI Medical Society event in Boston. His talk focuses on cancer as a mitochondrial metabolic disease rather than a genetic one.

Focusing on the mitochondrial-stem cell connection (MSCC,) the authors propose a protocol using vitamins, drugs, and dietary changes to target this process, aiming to disrupt cancer's energy sources and stem cells.

Looking at biological age instead of just chronological age, Dr. Eades examines a Michigan study linking grip strength to longevity.

Drug studies sponsored by drug manufacturers tend to report higher drug efficacy than studies not sponsored by the drug company, a new report published in the Journal of Political Economy on Oct. 7 finds.